Research Progress on Qingwen Baidu Decoction and Its Active Ingredients in Prevention of Lung Injury
10.13422/j.cnki.syfjx.20250206
- VernacularTitle:清瘟败毒饮及其活性成分防治肺损伤的研究进展
- Author:
Xiaojie LIN
1
;
Xianan WEN
1
;
Qiaolin ZENG
1
;
Li WANG
2
;
Yuanru ZHENG
3
;
Jie ZHAO
1
Author Information
1. School of Health Science，Guangdong Pharmaceutical University，Guangzhou 510006，China
2. College of Pharmacy，Guangzhou Health Science College，Guangzhou 510450，China
3. School of Pharmacy，Guangdong Pharmaceutical University，Guangzhou 510006，China
- Publication Type:Journal Article
- Keywords:
Qingwen Baidu decoction;
lung injury;
acute lung injury;
active ingredients;
mechanism of action
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2025;31(9):315-322
- CountryChina
- Language:Chinese
-
Abstract:
Acute lung injury （ALI） is a common and highly lethal clinical syndrome characterized by acute progressive respiratory failure. Currently， the treatment of ALI primarily involves respiratory support therapy and symptomatic pharmacotherapy， yet there is still a lack of specific and effective pharmacological treatments. Qingwen Baidu decoction is a traditional Chinese medicine formula that has the effects of clearing heat， removing toxin， cooling blood， and purging fire. Its pharmacological effects include anti-inflammatory， antipyretic， antibacterial， antiviral， sedative， and so on. The flavonoids， phenols， terpenes， and other components contained in this formula have strong pharmacological activity， which can regulate the inflammatory response caused and oxidative stress in ALI and maintain the integrity of alveolar-capillary barrier （ACB） by anti-apoptosis， anti-pathogen infection， and anti-pulmonary fibrosis， thereby improving the pathological changes of lung tissue. Among them， flavonoids have been reported more， and their mechanism of action is complex and diverse. For example， quercetin， luteolin， and baicalin act on multiple important targets， such as signal transducer and activator of transcription 3 （STAT3）， mitogen-activated protein kinase 3 （MAPK3）， etc. and participate in the regulation of Toll-like receptor 4 （TLR4）/myeloid differentiation primary response 88 （MyD88）/nuclear factor kappa B （NF-κB）， nuclear factor erythroid 2-related factor 2（Nrf2）/Kelch-like ECH-associated protein 1 （Keap1）， and silent information regulator 1 （SIRT1）/forkhead box protein O1 （FoxO1） signaling pathways， thereby intervening in pathological events such as inflammation， oxidative stress， cell apoptosis， and fibrosis. This paper aims to review the research progress on Qingwen Baidu decoction and its active ingredients in the prevention and treatment of lung injury in the expectation of providing reference for its subsequent pharmacological mechanism research and theoretical support for its clinical application and drug development in the treatment of ALI.
